187 related articles for article (PubMed ID: 1650650)
21. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
23. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization.
Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB
Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
[TBL] [Abstract][Full Text] [Related]
26. Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence.
Owen NE; Le Breton GC
Am J Physiol; 1981 Oct; 241(4):H613-9. PubMed ID: 6274207
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets.
Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L
Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747
[TBL] [Abstract][Full Text] [Related]
28. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Johnson GJ; Leis LA; Francis GS
Thromb Res; 1990 Jul; 59(1):139-48. PubMed ID: 2399526
[TBL] [Abstract][Full Text] [Related]
29. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
Riondino S; Gazzaniga PP; Pulcinelli FM
Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
31. Relaxant mechanisms of cyclic AMP-increasing agents in porcine coronary artery.
Yamagishi T; Yanagisawa T; Satoh K; Taira N
Eur J Pharmacol; 1994 Jan; 251(2-3):253-62. PubMed ID: 7512040
[TBL] [Abstract][Full Text] [Related]
32. Elevation of platelet cyclic AMP level by thromboxane A2/prostaglandin H2 receptor agonists.
Ishikawa Y; Ogawa A
Thromb Res; 1991 Dec; 64(6):667-76. PubMed ID: 1665927
[TBL] [Abstract][Full Text] [Related]
33. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.
Faili A; Randon J; Vargaftig BB; Hatmi M
Biochem Pharmacol; 1993 May; 45(9):1815-20. PubMed ID: 8388209
[TBL] [Abstract][Full Text] [Related]
34. Variable potency of nitrergic-nitrovasodilator relaxations of the mouse anococcygeus against different forms of induced tone.
Gibson A; McFadzean I; Tucker JF; Wayman C
Br J Pharmacol; 1994 Dec; 113(4):1494-500. PubMed ID: 7889307
[TBL] [Abstract][Full Text] [Related]
35. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
36. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives.
Pan IQ; Hall ER; Wu KK
Br J Haematol; 1984 Oct; 58(2):317-23. PubMed ID: 6089860
[TBL] [Abstract][Full Text] [Related]
37. Increased cytosolic phospholipase A2 activity is not accompanied by arachidonic acid liberation in U46619-stimulated rabbit platelets.
Akiba S; Abe T; Sato T
Biochem Mol Biol Int; 1995 Feb; 35(2):275-81. PubMed ID: 7663381
[TBL] [Abstract][Full Text] [Related]
38. Ca2+ influx induced by the agonist U46619 is inhibited by hyperpolarization induced by the K+ channel opener cromakalim in canine coronary artery.
Yamagishi T; Yanagisawa T; Taira N
Jpn J Pharmacol; 1992 Jul; 59(3):291-9. PubMed ID: 1434126
[TBL] [Abstract][Full Text] [Related]
39. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
40. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]